The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC).
 
Roger Li
Stock and Other Ownership Interests - crispr therapeutics; Guardant Health
Consulting or Advisory Role - Arquer Diagnostics; Bristol-Myers Squibb; FerGene; Ferring
Research Funding - CG Oncology
Expert Testimony - CG Oncology
Other Relationship - Predicine
 
Philippe E. Spiess
Leadership - Global Society of Rare Genitourinary Tumors; NCCN; Société Internationale d’Urologie Journal
Honoraria - UptoDate
Other Relationship - NCCN
(OPTIONAL) Uncompensated Relationships - Moffitt Cancer Center
 
Wade J. Sexton
Consulting or Advisory Role - pacific edge; Urogen pharma
 
Michael Adam Poch
No Relationships to Disclose
 
Logan Zemp
No Relationships to Disclose
 
Julio M. Pow-Sang
Consulting or Advisory Role - Lantheus Medical Imaging
 
Jingsong Zhang
Honoraria - AstraZeneca/MedImmune; Bayer; Dendreon; EMD Serono; Pfizer; Sanofi; Sanofi/Aventis; Seagen
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Dendreon; EMD Serono; Pfizer
Speakers' Bureau - AstraZeneca; Dendreon; Sanofi; Seagen
 
Jasreman Dhillon
No Relationships to Disclose
 
Gustavo Borjas
No Relationships to Disclose
 
Shreyas U Naidu
No Relationships to Disclose
 
Denise Dorman
No Relationships to Disclose
 
James M. Burke
Employment - CG Oncology
Stock and Other Ownership Interests - CG Oncology
Travel, Accommodations, Expenses - CG Oncology
 
James J Mule
Leadership - CG Oncology
 
Jose Conejo-Garcia
No Relationships to Disclose
 
Rohit K. Jain
Honoraria - Curio Science; DAVA Oncology; NCCN/Pfizer; OncLive/MJH Life Sciences
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; Gilead Sciences; Gilead Sciences; Pfizer; Seattle Genetics/Astellas
Speakers' Bureau - Gilead Sciences; Seagen; Seattle Genetics/Astellas
Research Funding - Bristol Myers Squibb; Gilead Sciences; NCI